In this article, the topic of Ibogamine will be addressed from a multidisciplinary approach, with the purpose of providing a broad and complete vision of this topic. Different perspectives and recent studies will be analyzed to offer the reader a deep and up-to-date understanding of Ibogamine. In addition, possible implications and practical applications of this topic in various areas will be explored, in order to highlight its relevance in contemporary society. Through this article, we seek to generate reflection and debate around Ibogamine, thus contributing to the enrichment of knowledge and the promotion of critical thinking.
![]() | |
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEBI | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C19H24N2 |
Molar mass | 280.415 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Ibogamine is an anti-convulsant, anti-addictive, CNS stimulant alkaloid found in Tabernanthe iboga and Crepe Jasmine (Tabernaemontana divaricata).[1][2][3] Basic research related to how addiction affects the brain has used this chemical.[4]
Ibogamine persistently reduced the self-administration of cocaine and morphine in rats.[5] The same study found that ibogamine (40 mg/kg) and coronaridine (40 mg/kg) did not produce "any tremor effects in rats that differ significantly from saline control". While the related alkaloids ibogaine (20–40 mg/kg), harmaline (10–40 mg/kg) and desethylcoronaridine (10–40 mg/kg) were "obviously tremorgenic".[5]
Ibogamine can be prepared from one-step demethoxycarbonylation process through coronaridine.[6]
Like ibogaine, it has seems to have similar pharmacology. It has effects on KOR,[7] NMDAR, nAChR[8] and serotonin sites.[9] It also inhibits acetylcholinesterase and butyrylcholinesterase.[10]